← Browse by Condition
Medical Condition
her2 negative breast carcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1, Phase 2
NCT07483307 Phase 2
Recruiting
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer
Enrollment
176 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT06026657 Phase 1, Phase 2
Recruiting
Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer
Enrollment
42 pts
Location
United States
Sponsor
Margaret Gatti-Mays